{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:27:29Z","timestamp":1791149249118,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/bcr2781","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T07:14:41Z","timestamp":1294298081000},"source":"Crossref","is-referenced-by-count":245,"title":["Breast cancer metastasis to the bone: mechanisms of bone loss"],"prefix":"10.1186","volume":"12","author":[{"given":"Yu-Chi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M","family":"Sosnoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M","family":"Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,16]]},"reference":[{"issue":"Suppl 7","key":"2760_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0080","volume":"7","author":"A Lipton","year":"2009","unstructured":"Lipton A, Uzzo R, Amato RJ, Ellis GK, Hakimian B, Roodman GD, Smith MR: The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors. J Natl Compr Canc Netw. 2009, 7 (Suppl 7): S1-29. quiz S30","journal-title":"J Natl Compr Canc Netw"},{"key":"2760_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer Statistics, 2007. CA Cancer J Clin. 2007, 57: 43-66. 10.3322\/canjclin.57.1.43.","journal-title":"CA Cancer J Clin"},{"key":"2760_CR3","volume-title":"Bone Remodeling and its Disorders","author":"GR Mundy","year":"1999","unstructured":"Mundy GR: Bone Remodeling and its Disorders. 1999, London: Martin Dunitz Ltd"},{"key":"2760_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1749-6632.1974.tb14480.x","volume":"230","author":"LG Raisz","year":"1974","unstructured":"Raisz LG, Mundy GR, Luben RA: Skeletal reactions to neoplasms. Ann N Y Acad Sci. 1974, 230: 473-475. 10.1111\/j.1749-6632.1974.tb14480.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2760_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0959-8049(00)00363-4","volume":"37","author":"J Lee","year":"2001","unstructured":"Lee J, Weber M, Mejia S, Bone E, Watson P, Orr W: A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu\/nu mice. Eur J Cancer. 2001, 37: 106-113. 10.1016\/S0959-8049(00)00363-4.","journal-title":"Eur J Cancer"},{"key":"2760_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00003086-200004000-00013","volume":"373","author":"DR Clohisy","year":"2000","unstructured":"Clohisy DR, Perkins SL, Ramnaraine ML: Review of cellular mechanisms of tumor osteolysis. Clin Orthop Relat Res. 2000, 373: 104-114. 10.1097\/00003086-200004000-00013.","journal-title":"Clin Orthop Relat Res"},{"key":"2760_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/154405910608500703","volume":"85","author":"UH Lerner","year":"2006","unstructured":"Lerner UH: Bone remodeling in post-menopausal osteoporosis. J Dent Res. 2006, 85: 584-595. 10.1177\/154405910608500703.","journal-title":"J Dent Res"},{"key":"2760_CR8","volume-title":"Annu Rev Pathol","author":"X Feng","year":"2010","unstructured":"Feng X, McDonald JM: Disorders of bone remodeling. Annu Rev Pathol. 2010,"},{"key":"2760_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00784-009-0268-2","volume":"13","author":"P Proff","year":"2009","unstructured":"Proff P, Romer P: The molecular mechanism behind bone remodelling: a review. Clin Oral Investig. 2009, 13: 355-362. 10.1007\/s00784-009-0268-2.","journal-title":"Clin Oral Investig"},{"key":"2760_CR10","first-page":"561","volume":"235","author":"A Zambonin Zallone","year":"1984","unstructured":"Zambonin Zallone A, Teti A, Primavera MV: Resorption of vital or devitalized bone by isolated osteoclasts in vitro. The role of lining cells. Cell Tissue Res. 1984, 235: 561-564.","journal-title":"Cell Tissue Res"},{"key":"2760_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1006\/bbrc.2001.5127","volume":"285","author":"S Corisdeo","year":"2001","unstructured":"Corisdeo S, Gyda M, Zaidi M, Moonga BS, Troen BR: New insights into the regulation of cathepsin K gene expression by osteoprotegerin ligand. Biochem Biophys Res Commun. 2001, 285: 335-339. 10.1006\/bbrc.2001.5127.","journal-title":"Biochem Biophys Res Commun"},{"key":"2760_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II: Bone remodeling. Ann N Y Acad Sci. 2006, 1092: 385-396. 10.1196\/annals.1365.035.","journal-title":"Ann N Y Acad Sci"},{"key":"2760_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA: Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia. 2005, 10: 169-180. 10.1007\/s10911-005-5399-8.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2760_CR14","first-page":"18","volume":"19","author":"TA Guise","year":"1998","unstructured":"Guise TA, Mundy GR: Cancer and bone. Endocr Rev. 1998, 19: 18-54. 10.1210\/er.19.1.18.","journal-title":"Endocr Rev"},{"issue":"Suppl","key":"2760_CR15","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","volume":"5","author":"TA Guise","year":"2005","unstructured":"Guise TA, Kozlow WM, Heras-Herzig A, Padalecki SS, Yin JJ, Chirgwin JM: Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer. 2005, 5 (Suppl): S46-53. 10.3816\/CBC.2005.s.004.","journal-title":"Clin Breast Cancer"},{"key":"2760_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/9780470623992.ch79","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"GR Mundy","year":"2008","unstructured":"Mundy GR, Sterling JL: Metastatic solid tumors to bone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Edited by: Rosen CL. 2008, Washington, DC: American Society for Bone and Mineral Research, 374-378. full_text. 7","edition":"7"},{"issue":"8 Suppl","key":"2760_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","volume":"80","author":"GR Mundy","year":"1997","unstructured":"Mundy GR: Mechanisms of bone metastasis. Cancer. 1997, 80 (8 Suppl): 1546-1556. 10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I.","journal-title":"Cancer"},{"issue":"8 Suppl","key":"2760_CR18","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M","volume":"80","author":"TA Guise","year":"1997","unstructured":"Guise TA: Parathyroid hormone-related protein and bone metastases. Cancer. 1997, 80 (8 Suppl): 1572-1580. 10.1002\/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M.","journal-title":"Cancer"},{"key":"2760_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/A:1026526703898","volume":"1","author":"AC Karaplis","year":"2000","unstructured":"Karaplis AC, Goltzman D: PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord. 2000, 1: 331-341. 10.1023\/A:1026526703898.","journal-title":"Rev Endocr Metab Disord"},{"key":"2760_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003, 3: 537-549. 10.1016\/S1535-6108(03)00132-6.","journal-title":"Cancer Cell"},{"key":"2760_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","volume":"33","author":"M Bendre","year":"2003","unstructured":"Bendre M, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ: Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone. 2003, 33: 28-37. 10.1016\/S8756-3282(03)00086-3.","journal-title":"Bone"},{"key":"2760_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.yexcr.2007.09.021","volume":"314","author":"M Kinder","year":"2008","unstructured":"Kinder M, Chislock E, Bussard KM, Shuman L, Mastro AM: Metastatic breast cancer induces an osteoblast inflammatory response. Exp Cell Res. 2008, 314: 173-183. 10.1016\/j.yexcr.2007.09.021.","journal-title":"Exp Cell Res"},{"key":"2760_CR23","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","volume":"6","author":"LA Kingsley","year":"2007","unstructured":"Kingsley LA, Fournier PG, Chirgwin JM, Guise TA: Molecular biology of bone metastasis. Mol Cancer Ther. 2007, 6: 2609-2617. 10.1158\/1535-7163.MCT-07-0234.","journal-title":"Mol Cancer Ther"},{"key":"2760_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1476-4598-9-122","volume":"9","author":"V Ganapathy","year":"2010","unstructured":"Ganapathy V, Ge R, Grazioli A, Xie W, Banach-Petrosky W, Kang Y, Lonning S, McPherson J, Yingling JM, Biswas S, Mundy GR, Reiss M: Targeting the transforming growth factor-beta pathway inhibits human basal-like breast cancer metastasis. Mol Cancer. 2010, 9: 122-10.1186\/1476-4598-9-122.","journal-title":"Mol Cancer"},{"key":"2760_CR25","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S: Minireview: the OPG\/RANKL\/RANK system. Endocrinology. 2001, 142: 5050-5055. 10.1210\/en.142.12.5050.","journal-title":"Endocrinology"},{"key":"2760_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ctrv.2010.04.003","volume":"36","author":"RE Coleman","year":"2010","unstructured":"Coleman RE, Lipton A, Roodman GD, Guise TA, Boyce BF, Brufsky AM, Cl\u00e9zardin P, Croucher PI, Gralow JR, Hadji P, Holen I, Mundy GR, Smith MR, Suva LJ: Metastasis and bone loss: Advancing treatment and prevention. Cancer Treat Rev. 2010, 36: 615-620. 10.1016\/j.ctrv.2010.04.003.","journal-title":"Cancer Treat Rev"},{"key":"2760_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/9780470623992.ch80","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"W McHayleh","year":"2008","unstructured":"McHayleh W, Ellerman J, Roodman D: Hematologic malignancies and bone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Edited by: Rosen CL. 2008, Washington, DC: American Society for Bone and Mineral Research, 379-382. full_text. 7","edition":"7"},{"key":"2760_CR28","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1158\/0008-5472.CAN-10-2179","volume":"70","author":"Y Yang","year":"2010","unstructured":"Yang Y, Ren Y, Ramani VC, Nan L, Suva LJ, Sanderson RD: Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL. Cancer Res. 2010, 70: 8329-8338. 10.1158\/0008-5472.CAN-10-2179.","journal-title":"Cancer Res"},{"key":"2760_CR29","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD: The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003, 349: 2483-2494. 10.1056\/NEJMoa030847.","journal-title":"N Engl J Med"},{"key":"2760_CR30","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1158\/1078-0432.CCR-09-0426","volume":"15","author":"S Pozzi","year":"2009","unstructured":"Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N: High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res. 2009, 15: 5829-5839. 10.1158\/1078-0432.CCR-09-0426.","journal-title":"Clin Cancer Res"},{"key":"2760_CR31","volume-title":"J Cell Biochem","author":"KM Bussard","year":"2010","unstructured":"Bussard KM, Venzon DJ, Mastro AM: Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. J Cell Biochem. 2010,"},{"key":"2760_CR32","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1158\/1078-0432.CCR-05-1806","volume":"12","author":"PA Phadke","year":"2006","unstructured":"Phadke PA, Mercer RR, Harms JF, Jia Y, Frost AR, Jewell JL, Bussard KM, Nelson S, Moore C, Kappes JC, Gay CV, Mastro AM, Welch DR: Kinetics of metastatic breast cancer cell trafficking in bone. Clin Cancer Res. 2006, 12: 1431-1440. 10.1158\/1078-0432.CCR-05-1806.","journal-title":"Clin Cancer Res"},{"key":"2760_CR33","volume-title":"Bone","author":"P Juarez","year":"2010","unstructured":"Juarez P, Guise TA: TGF-beta in cancer and bone: Implications for treatment of bone metastases. Bone. 2010,"},{"key":"2760_CR34","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/onc.2009.389","volume":"29","author":"J Akech","year":"2010","unstructured":"Akech J, Wixted JJ, Bedard K, van der Deen M, Hussain S, Guise TA, van Wijnen AJ, Stein JL, Languino LR, Altieri DC, Pratap J, Keller E, Stein GS, Lian JB: Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene. 2010, 29: 811-821. 10.1038\/onc.2009.389.","journal-title":"Oncogene"},{"key":"2760_CR35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pros.21075","volume":"70","author":"C Morrissey","year":"2010","unstructured":"Morrissey C, Lai JS, Brown LG, Wang YC, Roudiffer MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E, Nelson PS, Vessella RL: The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells. Prostate. 2010, 70: 412-424.","journal-title":"Prostate"},{"key":"2760_CR36","first-page":"907","volume":"2","author":"N Rucci","year":"2010","unstructured":"Rucci N, Teti A: Osteomimicry: how tumor cells try to deceive the bone. Front Biosci (Schol Ed). 2010, 2: 907-915. 10.2741\/S110.","journal-title":"Front Biosci (Schol Ed)"},{"key":"2760_CR37","first-page":"179","volume":"26","author":"T Standal","year":"2004","unstructured":"Standal T, Borset M, Sundan A: Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol. 2004, 26: 179-184.","journal-title":"Exp Oncol"},{"key":"2760_CR38","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ijc.24890","volume":"126","author":"V Elazar","year":"2010","unstructured":"Elazar V, Adwan H, Bauerle T, Rohekar K, Golomb G, Berger MR: Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis. Int J Cancer. 2010, 126: 1749-1760.","journal-title":"Int J Cancer"},{"key":"2760_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.abb.2008.02.030","volume":"473","author":"PJ Marie","year":"2008","unstructured":"Marie PJ: Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys. 2008, 473: 98-105. 10.1016\/j.abb.2008.02.030.","journal-title":"Arch Biochem Biophys"},{"key":"2760_CR40","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.1158\/0008-5472.CAN-08-1078","volume":"68","author":"J Pratap","year":"2008","unstructured":"Pratap J, Wixted JJ, Gaur T, Zaidi SK, Dobson J, Gokul KD, Hussain S, van Wijnen AJ, Stein JL, Stein GS, Lian JB: Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008, 68: 7795-7802. 10.1158\/0008-5472.CAN-08-1078.","journal-title":"Cancer Res"},{"key":"2760_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0531-5565(03)00069-X","volume":"38","author":"BR Troen","year":"2003","unstructured":"Troen BR: Molecular mechanisms underlying osteoclast formation and activation. Exp Gerontol. 2003, 38: 605-614. 10.1016\/S0531-5565(03)00069-X.","journal-title":"Exp Gerontol"},{"key":"2760_CR42","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/154405910608500704","volume":"85","author":"UH Lerner","year":"2006","unstructured":"Lerner UH: Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res. 2006, 85: 596-607. 10.1177\/154405910608500704.","journal-title":"J Dent Res"},{"key":"2760_CR43","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1210\/endo-86-6-1436","volume":"86","author":"DC Klein","year":"1970","unstructured":"Klein DC, Raisz LG: Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970, 86: 1436-1440. 10.1210\/endo-86-6-1436.","journal-title":"Endocrinology"},{"key":"2760_CR44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/bjc.1973.154","volume":"28","author":"TJ Powles","year":"1973","unstructured":"Powles TJ, Clark SA, Easty DM, Easty GC, Neville AM: The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer. 1973, 28: 316-321.","journal-title":"Br J Cancer"},{"key":"2760_CR45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0006-291X(02)02937-6","volume":"300","author":"T Ohshiba","year":"2003","unstructured":"Ohshiba T, Miyaura C, Ito A: Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis. Biochem Biophys Res Commun. 2003, 300: 957-964. 10.1016\/S0006-291X(02)02937-6.","journal-title":"Biochem Biophys Res Commun"},{"key":"2760_CR46","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1158\/1535-7163.MCT-08-0153","volume":"7","author":"T Takahashi","year":"2008","unstructured":"Takahashi T, Uehara H, Bando Y, Izumi K: Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth. Mol Cancer Ther. 2008, 7: 2807-2816. 10.1158\/1535-7163.MCT-08-0153.","journal-title":"Mol Cancer Ther"},{"key":"2760_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2407-6-181","volume":"6","author":"TL Larkins","year":"2006","unstructured":"Larkins TL, Nowell M, Singh S, Sanford GL: Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer. 2006, 6: 181-10.1186\/1471-2407-6-181.","journal-title":"BMC Cancer"},{"key":"2760_CR48","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/sj.bjc.6602417","volume":"92","author":"SE Aldridge","year":"2005","unstructured":"Aldridge SE, Lennard TW, Williams JR, Birch MA: Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone. Br J Cancer. 2005, 92: 1531-1537. 10.1038\/sj.bjc.6602417.","journal-title":"Br J Cancer"},{"key":"2760_CR49","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1158\/0008-5472.CAN-09-2758","volume":"70","author":"N Rucci","year":"2010","unstructured":"Rucci N, Millimaggi D, Mari M, Del Fattore A, Bologna M, Teti A, Angelucci A, Dolo V: Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer\/CD147. Cancer Res. 2010, 70: 6150-6160. 10.1158\/0008-5472.CAN-09-2758.","journal-title":"Cancer Res"},{"key":"2760_CR50","volume-title":"Bone","author":"CC Lynch","year":"2010","unstructured":"Lynch CC: Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis. Bone. 2010,"},{"key":"2760_CR51","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2353\/ajpath.2009.080906","volume":"175","author":"I Podgorski","year":"2009","unstructured":"Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, Olive MB, Sloane BF: Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol. 2009, 175: 1255-1269. 10.2353\/ajpath.2009.080906.","journal-title":"Am J Pathol"},{"key":"2760_CR52","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/sj.emboj.7600729","volume":"24","author":"JS Kang","year":"2005","unstructured":"Kang JS, Alliston T, Delston R, Derynck R: Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 2005, 24: 2543-2555. 10.1038\/sj.emboj.7600729.","journal-title":"EMBO J"},{"key":"2760_CR53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10585-004-1867-6","volume":"21","author":"RR Mercer","year":"2004","unstructured":"Mercer RR, Miyasaka C, Mastro AM: Metastatic breast cancer cells suppress osteoblast adhesion and differentiation. Clin Exp Metastasis. 2004, 21: 427-435. 10.1007\/s10585-004-1867-6.","journal-title":"Clin Exp Metastasis"},{"key":"2760_CR54","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1359\/jbmr.060610","volume":"21","author":"Y Wang","year":"2006","unstructured":"Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD: Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res. 2006, 21: 1350-1358. 10.1359\/jbmr.060610.","journal-title":"J Bone Miner Res"},{"key":"2760_CR55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000, 2: 737-744. 10.1038\/35036374.","journal-title":"Nat Cell Biol"},{"key":"2760_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1182\/blood-2009-08-237628","volume":"115","author":"FC Cackowski","year":"2010","unstructured":"Cackowski FC, Anderson JL, Patrene KD, Choksi RJ, Shapiro SD, Windle JJ, Blair HC, Roodman GD: Osteoclasts are important for bone angiogenesis. Blood. 2010, 115: 140-149. 10.1182\/blood-2009-08-237628.","journal-title":"Blood"},{"key":"2760_CR57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ph3030572","volume":"3","author":"M Raica","year":"2010","unstructured":"Raica M, Anca M: Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy. Pharmaceuticals. 2010, 3: 572-599. 10.3390\/ph3030572.","journal-title":"Pharmaceuticals"},{"key":"2760_CR58","doi-asserted-by":"publisher","first-page":"e3537","DOI":"10.1371\/journal.pone.0003537","volume":"3","author":"MA Sanchez-Fernandez","year":"2008","unstructured":"Sanchez-Fernandez MA, Gallois A, Riedl T, Jurdic P, Hoflack B: Osteoclasts control osteoblast chemotaxis via PDGF-BB\/PDGF receptor beta signaling. PloS one. 2008, 3: e3537-10.1371\/journal.pone.0003537.","journal-title":"PloS one"},{"key":"2760_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.yexcr.2005.07.029","volume":"310","author":"RR Mercer","year":"2005","unstructured":"Mercer RR, Mastro AM: Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K. Exp Cell Res. 2005, 310: 270-281. 10.1016\/j.yexcr.2005.07.029.","journal-title":"Exp Cell Res"},{"key":"2760_CR60","first-page":"62","volume":"13","author":"K Kubota","year":"2002","unstructured":"Kubota K, Sakikawa C, Katsumata M, Nakamura T, Wakabayashi K: PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF). J Biomol Tech. 2002, 13: 62-71.","journal-title":"J Biomol Tech"},{"key":"2760_CR61","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1158\/0008-5472.CAN-09-4092","volume":"70","author":"L Coenegrachts","year":"2010","unstructured":"Coenegrachts L, Maes C, Torrekens S, Van Looveren R, Mazzone M, Guise TA, Bouillon R, Stassen JM, Carmeliet P, Carmeliet G: Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation. Cancer Res. 2010, 70: 6537-6547. 10.1158\/0008-5472.CAN-09-4092.","journal-title":"Cancer Res"},{"key":"2760_CR62","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/sj.bjc.6601437","volume":"89","author":"JE Brown","year":"2003","unstructured":"Brown JE, Thomson CS, Ellis SP, Gutcher SA, Purohit OP, Coleman RE: Bone resorption predicts for skeletal complications in metastatic bone disease. Br J Cancer. 2003, 89: 2031-2037. 10.1038\/sj.bjc.6601437.","journal-title":"Br J Cancer"},{"key":"2760_CR63","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.rcl.2010.02.014","volume":"48","author":"BL Clarke","year":"2010","unstructured":"Clarke BL, Khosla S: Physiology of bone loss. Radiol Clin North Am. 2010, 48: 483-495. 10.1016\/j.rcl.2010.02.014.","journal-title":"Radiol Clin North Am"},{"key":"2760_CR64","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.0105-2896.2005.00326.x","volume":"208","author":"H Carlsten","year":"2005","unstructured":"Carlsten H: Immune responses and bone loss: the estrogen connection. Immunol Rev. 2005, 208: 194-206. 10.1111\/j.0105-2896.2005.00326.x.","journal-title":"Immunol Rev"},{"key":"2760_CR65","volume-title":"Bone","author":"LL Ooi","year":"2010","unstructured":"Ooi LL, Zheng Y, Stalgis-Bilinski K, Dunstan CR: The bone remodeling environment is a factor in breast cancer bone metastasis. Bone. 2010, [Epub ahead of print]"},{"key":"2760_CR66","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1158\/0008-5472.CAN-09-3194","volume":"70","author":"LL Ooi","year":"2010","unstructured":"Ooi LL, Zhou H, Kalak R, Zheng Y, Conigrave AD, Seibel MJ, Dunstan CR: Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res. 2010, 70: 1835-1844. 10.1158\/0008-5472.CAN-09-3194.","journal-title":"Cancer Res"},{"key":"2760_CR67","doi-asserted-by":"publisher","first-page":"9542","DOI":"10.1158\/0008-5472.CAN-07-1046","volume":"67","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Zhou H, Modzelewski JR, Kalak R, Blair JM, Seibel MJ, Dunstan CR: Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res. 2007, 67: 9542-9548. 10.1158\/0008-5472.CAN-07-1046.","journal-title":"Cancer Res"},{"key":"2760_CR68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/clpt.2009.312","volume":"87","author":"F Balkwill","year":"2010","unstructured":"Balkwill F, Mantovani A: Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther. 2010, 87: 401-406. 10.1038\/clpt.2009.312.","journal-title":"Clin Pharmacol Ther"},{"key":"2760_CR69","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2345","volume":"11","author":"DL Roy","year":"2009","unstructured":"Roy DL, Pathangey LB, Tinder TL, Schettini JL, Gruber HE, Mukherjee P: Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res. 2009, 11: R56-10.1186\/bcr2345.","journal-title":"Breast Cancer Res"},{"key":"2760_CR70","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10585-007-9112-8","volume":"24","author":"P Clezardin","year":"2007","unstructured":"Clezardin P, Teti A: Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis. 2007, 24: 599-608. 10.1007\/s10585-007-9112-8.","journal-title":"Clin Exp Metastasis"},{"issue":"3 Suppl","key":"2760_CR71","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/COC.0b013e3181deb9e5","volume":"33","author":"A Lipton","year":"2010","unstructured":"Lipton A: Bone continuum of cancer. Am J Clin Oncol. 2010, 33 (3 Suppl): S1-7. 10.1097\/COC.0b013e3181deb9e5.","journal-title":"Am J Clin Oncol"},{"issue":"Suppl 1","key":"2760_CR72","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.ctrv.2008.03.008","volume":"34","author":"A Lipton","year":"2008","unstructured":"Lipton A: Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone. Cancer Treat Rev. 2008, 34 (Suppl 1): S25-30. 10.1016\/j.ctrv.2008.03.008.","journal-title":"Cancer Treat Rev"},{"key":"2760_CR73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/SPC.0b013e32832f4149","volume":"3","author":"R Coleman","year":"2009","unstructured":"Coleman R, Gnant M: New results from the use of bisphosphonates in cancer patients. Curr Opin Support Palliat Care. 2009, 3: 213-218. 10.1097\/SPC.0b013e32832f4149.","journal-title":"Curr Opin Support Palliat Care"},{"key":"2760_CR74","first-page":"159","volume":"8","author":"A Stopeck","year":"2010","unstructured":"Stopeck A: Denosumab findings in metastatic breast cancer. Clin Adv Hematol Oncol. 2010, 8: 159-160.","journal-title":"Clin Adv Hematol Oncol"},{"key":"2760_CR75","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1056\/NEJMe1010459","volume":"363","author":"A Grey","year":"2010","unstructured":"Grey A: Teriparatide for bone loss in the jaw. N Engl J Med. 2010, 363: 2458-2459. 10.1056\/NEJMe1010459.","journal-title":"N Engl J Med"},{"key":"2760_CR76","first-page":"1987","volume":"59","author":"JA Nemeth","year":"1999","unstructured":"Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML: Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res. 1999, 59: 1987-1993.","journal-title":"Cancer Res"},{"key":"2760_CR77","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10585-006-9044-8","volume":"23","author":"J Halpern","year":"2006","unstructured":"Halpern J, Lynch CC, Fleming J, Hamming D, Martin MD, Schwartz HS, Matrisian LM, Holt GE: The application of a murine bone bioreactor as a model of tumor: bone interaction. Clin Exp Metastasis. 2006, 23: 345-356. 10.1007\/s10585-006-9044-8.","journal-title":"Clin Exp Metastasis"},{"key":"2760_CR78","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1158\/0008-5472.CAN-08-4437","volume":"69","author":"AM Mastro","year":"2009","unstructured":"Mastro AM, Vogler EA: A three-dimensional osteogenic tissue model for the study of metastatic tumor cell interactions with bone. Cancer Res. 2009, 69: 4097-4100. 10.1158\/0008-5472.CAN-08-4437.","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2781.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr2781\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2781.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T19:38:15Z","timestamp":1712086695000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2760"],"URL":"https:\/\/doi.org\/10.1186\/bcr2781","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"215"}}